Peginterferon beta-1a was associated with high adherence and satisfaction in patients with multiple sclerosis in a German real-world study

BACKGROUND: Peginterferon beta-1a was developed for treatment of relapsing–remitting multiple sclerosis (RRMS) to provide an interferon with increased exposure to facilitate adherence by reducing frequency of application. This non-interventional observational study investigated the adherence to pegi...

Descripción completa

Detalles Bibliográficos
Autores principales: Menge, Til, Rehberg-Weber, Karin, Taipale, Kirsi, Nastos, Ilias, Jauß, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983429/
https://www.ncbi.nlm.nih.gov/pubmed/33796146
http://dx.doi.org/10.1177/17562864211000461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983429/
https://www.ncbi.nlm.nih.gov/pubmed/33796146
http://dx.doi.org/10.1177/17562864211000461

Ejemplares similares